药物对比
Linagliptin vs Repaglinide
比较 Linagliptin（Tradjenta）与 Repaglinide 治疗2型糖尿病。作用机制、低血糖风险、给药方式和患者适用性的差异。
此页面暂无可用的对比维度。
临床背景
This comparison is triggered when choosing an add-on oral agent for type 2 diabetes after metformin, balancing postprandial control against hypoglycemia risk and dosing convenience.
结论
Linagliptin is often preferred for lower hypoglycemia risk and simpler dosing, but Repaglinide may suit patients needing targeted mealtime glucose control.
全部药物对比